Learn How Low Dose Naltrexone Treats a Variety of Conditions
Dinno Health will be hosting a free, live webinar from 7 to 8 p.m., October 6, 2021 on Zoom, to provide insight into the science, physiology and mechanisms of action of low dose naltrexone (LDN). Featured presenter, Sebastian Denison, RPh, FAARM (candidate) and Professional Compounding Centers of America (PCCA) clinical compounding pharmacist, will answer questions about the many conditions LDN may be beneficial for, including Hashimoto’s thyroiditis, multiple sclerosis, eosinophilic esophagitis, IBS, Crohn’s disease, ulcerative colitis, arthritis, fibromyalgia, inflammatory conditions of the skin, stress, anxiety, PTSD, vulvodynia, polycystic ovary syndrome and more.
This webinar is for anyone that suffers from symptoms of gastrointestinal, autoimmune, dermatological and pain conditions. A live Q&A with Denison is included.
Denison specializes in hormone replacement therapy, veterinary, pain and sports compounding services. He also was the manager of pharmacy operations with the 2010 Vancouver Winter Olympic/Paralympic Games, and then the manager of the Whistler Olympic Village Polyclinic Pharmacy. In addition to his role as a PCCA clinical compounding pharmacist, Denison works with both the U.S. and Canadian CORE compounding training education teams and the pharmacy student education team. He regularly speaks at physician, pharmacist and other healthcare professional education symposiums and events.
Cost: Free. Location: on Zoom. For more information, visit DinnoHealth.com.